🟢 Moderna is trading 6.74% up today as markets recover after September 16 Fed decision

Moderna is trading at $158.65, with a +6.74% gain during the September 17, 2026 session as broader U.S. markets recover after the Federal Reserve’s September 16 rate decision.

• S&P 500 is up 0.90% and Nasdaq Composite 1.28%, supporting risk appetite across growth and healthcare stocks.
• Biotech is stronger, with XBI up 2.55%.
• No fresh company-specific announcement was identified; the move appears primarily macro- and sector-driven.